The turnover of the wholesale of traditional Chinese and Western medicine in China has shown a fluctuating yet gradually increasing trend from 2013 to 2023. In 2023, it stood at 2.02 hundred billion Yuans Renminbi. Over the past two years, the turnover grew by 5.5% in 2023 and by 5.35% in 2022, indicating a steady rise. The compounded annual growth rate (CAGR) over the last five years (2019-2023) averaged at 6.9%.
Looking ahead, the forecasted data from 2024 to 2028 suggests a continued growth trajectory, although at a more moderate pace, with a forecasted 5-year CAGR of 3.57% leading to an anticipated 19.16% overall growth by 2028. Future trends to watch for include the integration of digital technologies in the supply chain, regulatory changes, and shifting consumer preferences towards traditional Chinese medicine, which could impact turnover dynamics. Additionally, market consolidation and the increasing focus on healthcare innovation will likely play significant roles in shaping the industry's future.
